Abstract
In one aspect, there is provided an antibody or a functional fragment thereof, wherein the antibody or functional fragment thereof is capable of binding specifically to high molecular weight melanoma associated antigen (HMW-MAA), and binding to an Fcε receptor.
Original language | English |
---|---|
Patent number | 2013050725 |
IPC | C07K 16/30 (2006.01), A61K 39/395 (2006.01), A61P 35/00 (2006.01) |
Publication status | Published - 12 Apr 2013 |